Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia

NCT02244268 · clinicaltrials.gov ↗

COMPLETED

Status

3629

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Hyperplasia

Interventions

DRUG: ALNA®

Sponsor

Boehringer Ingelheim